BENZODIAZEPINE DERIVATIVES
Rilmazafone .HCL
Rilmazafone (リスミー,, previously known as 450191-S) is a water-soluble benzodiazepine prodrug developed in Japan. It has sedative and hypnotic effects. Rilmazafone induces impairment of motor function and has hypnotic properties. Rilmazafone has no effect
$ 16.80
VIEW MORE
Deschloroclotizolam
Deschloroclotizolam is a thienotriazolodiazepine derivative which was first synthesised in 1979, but was never marketed. It has subsequently been sold as a designer drug, first being definitively identified in 2017. This product is intended for laborato
$ 19.20
VIEW MORE
FLUCLOTIZOLAM
Fluclotizolam is a thienotriazolodiazepine derivative which was first synthesised in 1979, but was never marketed. It has subsequently been sold as a designer drug, first being definitively identified in 2017. This product is intended for laboratory rese
$ 19.80
VIEW MORE
Nitromethaqualone
Nitromethaqualone is an kind of methaqualone that has similar sedative and hypnotic properties. It is significantly more potent (10x) compared to the parent compound; the typical dose is approximately 25 mg. However, the aromatic nitro group is metabolise
$ 5.20
VIEW MORE
Methylmethaqualone
Methylmethaqualone (MMQ) is a quinazolinone and an kind of methaqualone that has similar sedative and hypnotic properties to its parent compound (resulting from its agonist activity at the β subtype of the GABAA receptor), and is around the same potency.
$ 5.20
VIEW MORE
FLUBROMAZEPAM
Flubromazepam is a benzodiazepine derivative which was first synthesized in 1960, but was never marketed and did not receive any further attention or study until late 2012 when it appeared on the grey market as a novel designer drug. It is a structural
$ 11.00
VIEW MORE
Deschloroetizolam
Deschloroetizolam (also known as Etizolam-2) is a thienotriazolodiazepine that is the dechlorinated of the closely related to etizolam. The compound has been sold as a designer drug… This product is intended for laboratory research purposes only and are
$ 11.20
VIEW MORE
PYRAZOLAM
Pyrazolam (SH-I-04)is a benzodiazepine derivative originally developed by a team led by Leo Sternbach at Hoffman-La Roche in the 1970s, and subsequently "rediscovered" and sold as a designer drug starting in 2012. Pyrazolam has structural similarities t
$ 19.00
VIEW MORE
Sl-164
SL-164 is methaqualone developed in the late 1960s by a team at Sumitomo. SL-164 has similar sedative, hypnotic and anticonvulsant properties to the parent compound, but was never marketed for clinical use. This product is intended for laboratory resear
$ 2.50
VIEW MORE
BROMAZOLAM
BROMAZOLAM is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative, and antidepressant properties, it was never FDA approved and was never available to the public. This product is intended for laboratory research purposes only
$ 10.00
VIEW MORE
3-HYDROXYPHENAZEPAM
3-HYDROXYPHENAZEPAM is a benzodiazepine with hypnotic, sedative, anxiolytic, and anticonvulsant properties, Relative to phenazepam, 3-hydroxyphenazepam has diminished myorelaxant properties, but is about equivalent in most other regards.Like other benzodi
$ 9.00
VIEW MORE
NEWSLETTER
Subscribe to our email for the latest information